Form 8-K - Current report:
SEC Accession No. 0001104659-24-069653
Filing Date
2024-06-07
Accepted
2024-06-07 16:15:30
Documents
13
Period of Report
2024-06-06
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2416777d1_8k.htm   iXBRL 8-K 24391
  Complete submission text file 0001104659-24-069653.txt   195855

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA swtx-20240606.xsd EX-101.SCH 3030
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE swtx-20240606_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE swtx-20240606_pre.xml EX-101.PRE 22369
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2416777d1_8k_htm.xml XML 3575
Mailing Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902
Business Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902 203-883-9490
SpringWorks Therapeutics, Inc. (Filer) CIK: 0001773427 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39044 | Film No.: 241029619
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)